ClinicalTrials.gg
RecruitingNCT06923423STRIDES2Updated Jan 21, 2026

Effectiveness, Implementation, and Cost of Cognitive Processing Therapy in Prisons

An interventional study of Group Cognitive Processing Therapy (CPT) and Control Group Individual trauma focused self-help via workbook in PTSD - Post Traumatic Stress Disorder, PTSD and Alcohol Use Disorder and PTSD and Trauma-related Symptoms, sponsored by University of Arkansas. Recruiting at 6 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-21.

Sponsored by University of Arkansas · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
640
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Combat Disorders with a site in United States — 41 open to participants now, 44 under way, 2 of them phase 3. Combat Disorders · United States.

Planned enrollment
3rd of 100
640 · median 74
Started
2025
with 21 others
No phase
72 of 114
26 open now
Primary completion
2028-12
later than 29 of 43 live
Registered
75th of 114
by date

Among the 114 studies in Combat Disorders with a site in United States, this one is the 3rd largest by planned enrollment of the 100 interventional ones that give a count, is one of 22 that started in 2025, is one of 72 with no phase, reaches primary completion later than 29 of the 43 other live ones, and was the 75th registered.

Combat Disorders

204 studies on the registry are indexed under Combat Disorders; 93 are open to participants now.

Browse Combat Disorders studies →

Open to participants now

41 of the 114 studies in Combat Disorders with a site in United States are open now. Recruiting first, the newest first:

35 more — sign in →

All 41 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 53 Combat Disorders studies recruiting now, 22 (42%) set no upper age limit and 26 (49%) stop at 75 or younger; 10 take children under 18; 5 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Combat Disorders with a site in United States, or all of them as a file.
02

Study summary

Addiction and trauma exposure are common among the 5.5 million people (1 in 47 adults) in the U.S. who are in prison or under supervision. About 85% of people in prison have a substance use disorder or are there for a drug-related crime, and many have experienced serious trauma before being incarcerated. Posttraumatic stress symptoms (PTSS) are often a result of trauma and are linked to more severe drug use, higher rates of relapse, and increased crime. PTSS and substance use disorder (SUD) each raise the chances of new arrests for people who are justice-involved, showing that addressing trauma and addiction could help reduce repeat offenses and the costs of incarceration. However, treatments for PTSS are rarely available in prisons, and there is little research on whether providing therapy for PTSS in prison can lower drug use, PTSS, or crime after release.

The goal of this clinical trial is to see if trauma-focused group therapy (CPT) provided while in prison, can help people after release from prison. The therapy has been adapted for use in prisons (CPT-CJ) and will be compared to trauma focused therapy delivered via a self-help workbook

This study will:

  • test whether a trauma-focused group therapy (CPT-CJ) can reduce post-incarceration drug and alcohol use, mental health issues, and drug-related crime, compared to trauma-focused self-help,
  • evaluate a strategy called implementation facilitation, which helps support the use of this therapy in prisons, and
  • measure the cost of the therapies and support strategies to help plan for future expansion.

Incarcerated participants (N = 640; 50% female) will be enrolled from \~10 prisons in \~5 states, ensuring variability in population and setting characteristics. They will:

  • take surveys and answer questions up to 5 times (before starting treatment, right after getting treatment, right before leaving prison, 3 months after leaving prison and 6 months after leaving prison)
  • complete CPT group therapy or self-help therapy
  • provide urine samples 3 months and 6 months after leaving prison

Prison stakeholders (e.g., prison staff, prison leadership, governmental officials; N = \~15 per site) who will be purposively sampled based on their role in CPT-CJ implementation will also participate in some surveys.

03

Conditions studied

  • PTSD - Post Traumatic Stress Disorder
  • PTSD and Alcohol Use Disorder
  • PTSD and Trauma-related Symptoms
  • Substance Use Disorder (SUD)
  • Depression
  • Mental Health
  • Trauma
  • Trauma Exposure
  • Traumatic Stress Disorder
  • Traumatic Stress
  • Post Traumatic Stress Symptoms

Keywords

  • Post traumatic Stress Disorder
  • Post traumatic Stress Symptoms
  • Substance Use
  • Substance Use Disorder
  • Cognitive Processing Therapy
  • Cognitive Processing Therapy for Criminal Justice Setting
  • Trauma focused self help
  • Facilitation
  • Implementation Facilitation
  • Implementation
  • Cost Estimation and Offsets
  • Drug Use Disorder
  • Alcohol Use Disorder
  • Trauma
  • Depression
  • Adult
  • Incarcerated
  • Prison
  • Imprisonment
  • Intervention
  • Treatment Comparison
  • Acceptability
  • Feasibility
  • Budget Impact
  • Cost Estimate
  • Implementation Evaluation
  • Recidivism
  • Self Help
  • Workbook
  • Criminal Justice
  • Effectiveness
  • Evidence Based Intervention
  • CPT
  • CPT-CJ
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • 18 years of age or older
  • Able to understand and speak English
  • Able to give
  • All items listed in "Inclusion criteria for all participants"
  • Be currently incarcerated in one of the prisons that have partnered as study sites
  • Have met criteria for a drug use disorder in the year prior to their current incarceration (≥ 2 symptoms on a drug use disorder checklist)
  • Have used drugs in the 30 days prior to their current incarceration
  • Have a history of traumatic event exposure
  • Endorse posttraumatic stress symptoms (score ≥ 4 on the Primary Care PTSD Screen for DSM-5; PC-PTSD-5)
  • Expect to be incarcerated for at least long enough to complete CPT-CJ as it is being implemented at the particular site (i.e., anticipated to be \~3 months, but will depend on dates associated with next available intervention group)
  • Expect to be released from prison within 12 months following the end of treatment (i.e., within \~15 months of the pre-treatment assessment)
  • Willing to consent to randomization to treatment condition

Exclusion criteria for prisoners (additional requirements assessed during pre-treatment assessments or indicated by prison staff; will result in being withdrawn from the study prior to randomization by the PI):

  • Unable to provide any locator information for post-release assessments
  • Determined to be releasing sooner than would allow the individual to complete CPT-CJ
  • Determined to have an unavoidable scheduling conflict or facility restriction (e.g., disciplinary, medical) that would prevent participation in CPT-CJ. Of note, if the scheduling conflict or facility restriction is expected to resolve following the next round of randomization at the study site, the participant may be put on "hold for next round" status rather than withdrawn unless other exclusionary criteria would be met by that time (e.g., release).
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
640 participants (estimated)

Study arms

  • Active comparator
    Group Cognitive Processing Therapy (CPT)

    Participants in CPT group therapy will learn about trauma and how to change upsetting thoughts related to it. Participants will attend up to a total of 12 sessions held 1-2x/week for 90 minutes. No more than 10 participants will be in a group. In this study, CPT provided is a version that was adapted for prisons (CPT-CJ).

    Behavioral: Group Cognitive Processing Therapy (CPT)

  • Active comparator
    Individual trauma focused self-help via workbook

    Participants in the trauma-focused self-help therapy will independently read and do practice assignments in a workbook to learn skills to recover from trauma.

    Behavioral: Control Group Individual trauma focused self-help via workbook

Interventions

  • BehavioralGroup Cognitive Processing Therapy (CPT)

    Participants in CPT group therapy will learn about trauma and how to change upsetting thoughts related to it. Participants will attend up to a total of 12 sessions held 1-2x/week for 90 minutes. No more than 10 participants will be in a group. In this study, CPT provided is a version that was adapted for prisons.

    Also known as: CPT-CJ

  • BehavioralControl Group Individual trauma focused self-help via workbook

    The self-help therapy is a therapy that people do on their own using a workbook. By reading and doing practice assignments in the workbook, people can learn skills to recover from trauma.

06

What researchers measure

Primary outcomes

  1. Drug Use Frequency (Count)

    Participants complete a Timeline Follow Back Interview assessment of illicit drug use during the previous 30 days at 3- \& 6-months post-release from prison. The total number of days of drug use will be summed to represent drug use frequency.

    Time frame: 3- and 6-month post-release from prison

  2. Drug use (Binary)

    Participants complete a Timeline Follow Back Interview assessment of illicit drug use during the previous 30 days at 3- \& 6-months post-release from prison. The total number of days of drug use will be dichotomized to indicate presence or absence of drug use since release.

    Time frame: 3- and 6-month post-release from prison

  3. Posttraumatic Stress Symptom Severity (Sum)

    Participants complete the PTSD Checklist for DSM-5 (PCL-5) at all assessments to examine change the effectiveness of the intervention and control groups on posttraumatic stress symptom severity. Scores range from 0-80 with higher scores indicating more severe PTSD symptoms.

    Time frame: Pre-treatment assessments will be ~2 wks before tx starts; post-treatment will be ~2 wks after tx ends; pre-release will be ~3 days before release; post-release follow-ups will be 3- and 6-mo after prison exist

  4. Treatment fidelity (ratio)

    The ratio of the number of CPT-CJ components delivered to the number of CPT-CJ components planned per completed fidelity monitoring templates.

    Time frame: Fidelity assessments will be done during the active treatment period which can be as short as 6 weeks to as long as 3 months for participants. The active treatment period is expected to span 1.5 years at each site.

Secondary outcomes

  1. Drug Use Disorder Symptom Severity (Count)

    Participants will complete a DSM-5 checklist of drug use disorder diagnostic criteria. The checklist can result in a maximum score of 11, with scores of 2 or greater indicating the presence of symptoms likely to meet diagnostic criteria. Scores will represent the total number of symptoms currently endorsed.

    Time frame: 3- and 6-months post-release from prison

  2. Drug Use Disorder (Binary)

    Participants will complete a DSM-5 checklist of drug use disorder diagnostic criteria. The checklist can result in a maximum score of 11, with scores of 2 or greater indicating the presence of symptoms likely to meet diagnostic criteria. Scores will represent the total number of symptoms currently endorsed. Sum score will be used to determine substance use disorder presence (i.e., scores ≥ 2) or absence (scores of 0-1).

    Time frame: 3- and 6-months post-release from prison

  3. Depressive Symptom Severity (Sum)

    Participants will complete the Patient Health Questionnaire - 8-item (PHQ-8) at all assessments to examine change the effectiveness of the intervention and control groups on depressive symptom severity. Scores range from 0-24 with higher scores indicating more severe depressive symptoms.

    Time frame: Pre-treatment assessments will be done ~2 wks before tx starts; post-treatment will be ~2 wks after tx ends; pre-release will be ~3 days before release; post-release follow-ups will be ~3- and ~6-mo after prison exit

  4. Alcohol Use Frequency (Count)

    Participants will complete a Timeline Follow Back Interview assessment of alcohol use during the previous 30 days at both 3- and 6-months post-release from prison. The total number of days of alcohol use will be summed to represent drug use frequency.

    Time frame: 3- and 6-months post-release from prison

  5. Alcohol Use (Binary)

    Participants will complete a Timeline Follow Back Interview assessment of alcohol use during the previous 30 days at both 3- and 6-months post-release from prison. The total number of days of alcohol use will be dichotomized to indicate presence or absence of alcohol use since release.

    Time frame: 3- and 6-months post-release from prison

  6. Alcohol Use Disorder Symptom Severity (Count)

    Participants will complete a DSM-5 checklist of alcohol use disorder diagnostic criteria. The checklist can result in a maximum score of 11, with scores of 2 or greater indicating the presence of symptoms likely to meet diagnostic criteria. Scores will represent the total number of symptoms currently endorsed.

    Time frame: 3- and 6-months post-release from prison

  7. Alcohol Use Disorder (Binary)

    Participants will complete a DSM-5 checklist of alcohol use disorder diagnostic criteria. The checklist can result in a maximum score of 11, with scores of 2 or greater indicating the presence of symptoms likely to meet diagnostic criteria. Scores will represent the total number of symptoms currently endorsed. Sum score will be used to determine substance use disorder presence (i.e., scores ≥ 2) or absence (scores of 0-1).

    Time frame: 3- and 6-months post-release from prison

  8. Drug-Related Crime Frequency (Count)

    Sum of new arrests and new convictions for drug charges based on the Criminal and Legal Activities Form and, if sufficient data is available, administrative records.

    Time frame: 6-months post-release from prison

  9. Drug Related Crime (Binary)

    Presence or absence of any new arrests or new convictions for drug charges based on the Criminal and Legal Activities Form and, if sufficient data is available, administrative records.

    Time frame: 6-months post-release from prison

  10. Substance-Related Disciplinary Violations (Count)

    Sum of substance-related disciplinary violations received while incarcerated per administrative records

    Time frame: Interval between treatment completion and release from incarceration, which could be as short as 1 day and as long as ~2 years

  11. Substance-Related Disciplinary Violations (Binary)

    Presence or absence of any substance-related disciplinary violations received while incarcerated per administrative records.

    Time frame: Interval between treatment completion and release from incarceration, which could be as short as 1 day and as long as ~2 years

  12. Positive Urine Drug Screens (Binary)

    Presence or absence of any positive urine drug screens following release from prison per department of corrections administrative records.

    Time frame: 3- and 6-months post-release from prison

  13. Treatment Acceptability (mean)

    Prison residents and stakeholders will complete the Acceptability of Intervention Measure (AIM) to index treatment acceptability. Mean scores on the AIM range from 1-5, with higher scores indicating greater intervention acceptability.

    Time frame: Post-treatment assessments will be completed 2 weeks after treatment ends (for residents). Immediately and 12-months post-implementation (for prison stakeholders)

  14. Treatment Acceptability (sum)

    Prison residents will complete the Client Satisfaction Questionnaire (CSQ-8) as an additional index of treatment acceptability. Sum scores on the CSQ-8 range from 8-32, with higher scores indicating greater intervention acceptability.

    Time frame: Administered at post-treatment assessment, which will be completed ~2 weeks after treatment ends

  15. Treatment appropriateness (mean)

    The Intervention Appropriateness Measure (IAM) will be completed by both prison residents and prison stakeholders. Mean scores on the IAM range from 1-5, with higher scores indicating greater intervention appropriateness.

    Time frame: Post-treatment assessments will be completed ~2 weeks after treatment ends (for residents). Immediately and 12-months post-implementation (for prison stakeholders)

  16. Treatment feasibility (mean)

    The Feasibility of Intervention Measure (FIM) will be completed by prison stakeholders to index treatment feasibility. Mean scores on the FIM range from 1-5, with higher scores indicating greater intervention feasibility.

    Time frame: Immediately and 12-months post-implementation

  17. Treatment adoption (ratio)

    Ratio of patients who completed CPT-CJ to the number who were randomized

    Time frame: Treatment adoption assessment will be done during the active treatment period, which can be as short as 6 weeks to as long as 3 months for participants. The active treatment period is expected to span 1.5 years at each site

  18. Treatment sustainability (ratio)

    The number of sites of total that are maintaining or increasing in CPT-CJ provision with high fidelity after implementation facilitation support is withdrawn.

    Time frame: 1-year post-implementation

07

Study locations

5 of 6 sites recruiting
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205, United States
    Not yet recruiting
    • Melissa J Zielinski, PhD · ContactMJZielinski@uams.edu · 501-526-8229
    • Melissa J Zielinski, PhD · Principal investigator
  • Northeast Arkansas Community Corrections Center (NEACC)
    Osceola, Arkansas 72370, United States
    Recruiting
  • Southwest Arkansas Community Correction Center
    Texarkana, Arkansas 71854, United States
    Recruiting
    • John Miners · Contact
  • East Central Arkansas Community Correction Center
    West Memphis, Arkansas 72301, United States
    Recruiting
    • Tameka Coleman · Contact
  • North Dakota State Penitentiary (NDSP)
    Bismarck, North Dakota 58501, United States
    Recruiting
  • Heart River Correctional Center (HRCC)
    Bismarck, North Dakota 58502, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Dec 2028, 41 months after the start.

Of 76 non-industry interventional studies with no phase under Combat Disorders, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 41 months is above that.

Counting every sponsor, half of 82 studies reached it within 25 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 3, 2025
First posted
Apr 11, 2025
StartActual
Jul 7, 2025
Primary completionEst.
Dec 2028
CompletionEst.
Dec 2028
Last update
Jan 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06923423
Responsible party
Sponsor
First posted
Apr 11, 2025
Start date
Jul 7, 2025
Primary completion
Dec 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Jan 21, 2026

Study contacts

Melissa J Zielinski, PhD
Contact
MJZielinski@uams.edu
501-526-8229
Mollee K Smith Steely, PhD
Contact
MKSteelysmith@uams.edu
501-320-7271
Melissa J Zielinski, PhD
principal investigator · University of Arkansas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion